NAV Loans

  • Borrowing by private equity firms at the fund level.
  • Ted Seides argues it is an end-of-cycle phenomenon.
  • NAV loans strike me as a canary in the coal mine signaling the end of the private equity boom. According to Preqin, 645 firms have not raised a new vehicle since 2015. With interest rates higher and the fundraising environment tighter, credit is scarce. NAV loans feel like the “extend and pretend” activity we saw after the GFC. For every Vista NAV loan, there are probably ten used to cure the woes of a GP.

Eric Schmidt on AI

  • Interview between Goldman Chair/CEO David Solomon and former CEO/Chair of Google on the future of Generative AI is worth a read.
  • In general, the disruption occurs first in the industries that have the most amount of money and the least amount of regulation.
  • Pairs nicely with this analysis of the latest batch of Y-combinator companies that are using AI/ML startups (139 in total!) and what areas they are working on.

Edward Luttwak

  • Interview with the military and grand strategy author – Edward Luttwak – thought-provoking throughout.
  • America’s power abroad, especially in Asia but increasingly with a resurgent Nato, is strong due to its alliances.
  • But this power is useless unless you have cohesion at home. There America is experiencing a cultural war.
  • Parallels with the Roman Empire are clear – “I think we could last another couple hundred years, but not much longer. For Rome, they had barbarian migrations and, of course, an ideological break that was fatal. Rome’s institutions were remarkable, and their concept of citizenship was something deep and profound, but the Romans were overwhelmed demographically.”

Attractiveness and Fund Manager Performance

  • In this paper, we study the relationship between stock fund managers’ facial attractiveness and fund outcomes. Utilizing the state-of-art deep learning technique to quantify facial attractiveness, we find that funds with facial unattractive managers outperform funds with attractive managers by over 2% per annum. We next show that good-looking managers attract significant higher fund flow especially if the funds are available on Fintech platforms where their photos are accessible to investors. Good-looking managers also have greater chance of promotion and tend to move to small firms. The potential explanations for their underperformance include inadequate ability, insufficient effort, overconfidence and inefficient site visits.

History of Powerpoint

  • Fascinating history of how we all ended up doing PowerPoint slides all the time.
  • The creator of PowerPoint also has a colourful story – “It’s hard now to imagine deafening applause for a PowerPoint—almost as hard as it is to imagine anyone but Bob Gaskins standing at this particular lectern, ushering in the PowerPoint age. Presentations are in his blood. His father ran an A/V company, and family vacations usually included a trip to the Eastman Kodak factory. During his graduate studies at Berkeley, he tinkered with machine translation and coded computer-generated haiku. He ran away to Silicon Valley to find his fortune before he could finalize his triple PhDs in English, linguistics, and computer science, but he brought with him a deep appreciation for the humanities, staffing his team with like-minded polyglots, including a disproportionately large number of women in technical roles. Because Gaskins ensured that his offices—the only Microsoft division, at the time, in Silicon Valley—housed a museum-worthy art collection, PowerPoint’s architects spent their days among works by Frank Stella, Richard Diebenkorn, and Robert Motherwell.” 

Alcohol and Ozempic/Wegovy

  • More and more anecdotal evidence suggests that GLP-1 agonists (like semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic (off label)) could dampen cravings for alcohol.
  • A survey of individuals taking these drugs by Morgan Stanley has confirmed this phenomenon.
  • Up to six clinical trials are testing semaglutide in alcohol use disorder – which could provide conclusive proof.
  • Investors are generally trying to determine the implications of the weight-loss revolution. As this chart shows the number of expert calls done by investors on AlphaSense on the topic has risen rapidly.
  • Alpha Sense also has a handy guide to the Obesity space here (need to sign up).

Chief AI Scientist at Meta Talk

  • Yann Lecun is the Turing Award winning professor at NYU and Chief Scientist for AI at Meta.
  • His latest talk at MIT is worth a listen.
  • It is a bit technical but left me with a feeling that though LLMs are a big breakthrough, they have big limitations.
  • Models beyond the autoregressive LLM that start to mimic some of the planning and reasoning required to rival human intelligence are a lot more complicated with not-so-neat solutions.

Biology as Engineering

  • What if drug development could one day be like engineering?
  • Artificial intelligence has the potential to make this a reality, as is so well explored in this accessible Forbes profile.
  • One of the most exciting parts they highlight is de novo protein design i.e. building proteins from nothing (this is a nice post about it from Derek Lowe).

Scientific Revolutions

  • Fascinating chart showing how scientific revolutions progressed 1300-1850 between different countries.
  • Here, we leverage large datasets of individual biographies (N = 22,943) and present the first estimates of scientific production during the late medieval and early modern period (1300–1850). Our data reveal striking differences across countries, with England and the United Provinces being much more creative than other countries, suggesting that economic development has been key in generating the Scientific Revolution.
  • Source: Cambridge University.
WordPress Cookie Notice by Real Cookie Banner